Anúncio
Anúncio

CRSP

CRSP logo

CRISPR Therapeutics AG

53.82
USD
Patrocinado
+1.38
+2.62%
02 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

53.75

-0.07
-0.12%

Relatórios de Lucros CRSP

Rácio de surpresa positiva

CRSP separação 20 de 37 últimas estimativas.

54%

Próximo Relatório

Data do Próximo Relatório
09 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$5.43M
/
-$1.21
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+510.84%
/
+3.42%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-84.79%
/
+175.00%

CRISPR Therapeutics AG earnings per share and revenue

On 10 de nov. de 2025, CRSP reported earnings of -1.17 USD per share (EPS) for Q3 25, beating the estimate of -1.27 USD, resulting in a 8.57% surprise. Revenue reached 889.00 mil, compared to an expected 9.08 milhão, with a -90.21% difference. The market reacted with a -0.98% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 26 analistas forecast an EPS of -1.21 USD, with revenue projected to reach 5.43 milhão USD, implying an aumentar of 3.42% EPS, and aumentar of 510.84% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
logo
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
For Q3 2025, CRISPR Therapeutics AG reported EPS of -$1.17, beating estimates by 8.57%, and revenue of $889.00K, -90.21% below expectations.
The stock price moved down -0.98%, changed from $55.12 before the earnings release to $54.58 the day after.
The next earning report is scheduled for 09 de fev. de 2026.
Based on 26 analistas, CRISPR Therapeutics AG is expected to report EPS of -$1.21 and revenue of $5.43M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio